P. Armitage and G. Berry, Statistical Methods in Medical Research, p.131, 1994.

P. Arnett, S. Rao, J. Grafman, L. Bernardin, T. Luchetta et al., Executive functions in multiple sclerosis: An analysis of temporal ordering, semantic encoding, and planning abilities., Neuropsychology, vol.11, issue.4, pp.535-544, 1997.
DOI : 10.1037/0894-4105.11.4.535

F. Barkhof, M. Filippi, D. H. Miller, P. Scheltens, . Campi et al., Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain, vol.120, issue.11, pp.2059-2069, 1997.
DOI : 10.1093/brain/120.11.2059

B. Bender and J. Lerner, Mood and Memory Changes in Asthmatic Children Receiving Corticosteroids, Journal of the American Academy of Child & Adolescent Psychiatry, vol.27, issue.6, pp.720-725, 1988.
DOI : 10.1097/00004583-198811000-00010

R. Benedict, D. Cookfair, R. Gavett, M. Gunther, F. Munschauer et al., Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS), Journal of the International Neuropsychological Society, vol.41, issue.04, pp.549-558, 2006.
DOI : 10.1002/ana.1032

H. Beshay and A. Pumariega, Sertraline Treatment of Mood Disorder Associated with Prednisone: A Case Report, Journal of Child and Adolescent Psychopharmacology, vol.8, issue.3, pp.187-93, 1998.
DOI : 10.1089/cap.1998.8.187

S. Borman, SUICIDE FOLLOWING CORTISONE TREATMENT, Journal of the American Medical Association, vol.146, issue.4, pp.337-338, 1951.
DOI : 10.1001/jama.1951.63670040004007b

S. Brown, A. David, . Khan, A. Vicki, and . Nejtek, The psychiatric side effects of corticosteroids, Annals of Allergy, Asthma & Immunology, vol.83, issue.6, 1999.
DOI : 10.1016/S1081-1206(10)62858-X

S. Brown, M. Trisha, D. A. Khan, . Carmody, and J. Thomas, Mood Changes During Prednisone Bursts in Outpatients With Asthma, Journal of Clinical Psychopharmacology, vol.22, issue.1, pp.55-61, 2002.
DOI : 10.1097/00004714-200202000-00009

S. Brown, W. Chamberlain, and N. Dhanani, An open-label trial of olanzapine for corticosteroid-induced mood symptoms, Journal of Affective Disorders, vol.83, issue.2-3, pp.277-285, 2004.
DOI : 10.1016/j.jad.2004.07.001

E. Brown, G. Stuard, and J. Liggin, Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy, Biological Psychiatry, vol.57, issue.5, pp.543-548, 2005.
DOI : 10.1016/j.biopsych.2004.11.021

E. Brown, L. Beard, A. Frol, and A. Rush, Effect of two prednisone exposures on mood and declarative memory, Neurobiology of Learning and Memory, vol.86, issue.1, pp.28-34, 2006.
DOI : 10.1016/j.nlm.2005.12.009

E. Brown, E. Vera, A. B. , D. J. Woolston, B. S. et al., Effects of chronic prednisone therapy on mood and memory, Journal of Affective Disorders, vol.99, issue.1-3, pp.1-3, 2007.
DOI : 10.1016/j.jad.2006.09.004

E. Brown, Effects of Glucocorticoids on Mood, Memory, and the Hippocampus, Annals of the New York Academy of Sciences, vol.10, issue.1, 2009.
DOI : 10.1016/S0033-3182(93)71910-6

H. Brønnum-hansen, E. Stenager, and N. Koch-henriksen, Suicide among Danes with multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.10, pp.1457-1466, 2005.
DOI : 10.1136/jnnp.2004.056747

B. William, F. Jan, and . Bethesda, Possibility of Biochemical Test for Suicidal Potential. An Analysis of Endocrine Findings Prior to Three Suicides, The JAMA Network, 1965.

W. Bunney and J. Fawcett, Bio-chemical research in dépression and suicide in suicidal behavior : Diagnosis and Management, 1968.

K. Budur and L. Pozuelo, Olanzapine for Corticosteroid-Induced Mood Disorders, Psychosomatics, vol.44, issue.4, p.353, 2003.
DOI : 10.1176/appi.psy.44.4.353

J. Burton, O. Connor, P. Hohol, M. Beyene, and J. Cochrane-database, Oral versus intravenous steroids for treatment of relapses in multiple sclerosis, Cochrane Databse . Syst Rev, 2012.

S. Campbell, Delirium after cessation of glucocorticoid therapy, General Hospital Psychiatry, vol.13, issue.4, pp.270-272, 1991.
DOI : 10.1016/0163-8343(91)90129-K

M. F. Carta, L. Moro, and . Lore, The risk of Bipolar Disorders in Multiple Sclerosis Trincas, E

. Carle, Corticotherapy and suicidal behavior: A case report, Encephale, p.2016
URL : https://hal.archives-ouvertes.fr/hal-01288213

L. Chan, D. Oliver, and P. Morris, High-and low-dose prednisolone for Transplant, Proc, vol.13, pp.336-338, 1981.

L. Chwastiak and E. Dawn, Psychiatric Issues in Multiple Sclerosis, Psychiatric Clinics of North America, vol.30, issue.4, pp.803-817, 2007.
DOI : 10.1016/j.psc.2007.07.003

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706287

C. Confavreux, G. Aimard, and M. Devic, COURSE AND PROGNOSIS OF MULTIPLE SCLEROSIS ASSESSED BY THE COMPUTERIZED DATA PROCESSING OF 349 PATIENTS, Brain, vol.103, issue.2, pp.281-300, 1980.
DOI : 10.1093/brain/103.2.281

C. Confavreux, S. Vukusic, T. Moreau, and P. Adeleine, Relapses and progression of disability in multiple sclerosis. New Engl, J. Med, vol.343, issue.20, pp.1430-1438, 2000.

. Confavreuxc, S. Vukusic, and P. Adeleine, Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process, Brain, vol.126, issue.4, pp.770-782, 2003.
DOI : 10.1093/brain/awg081

C. Travener, K. , and C. Bell, Corticoids Dosing for Flares in Relapsing Remitting Multiple Sclerosis, 2017.

D. Cosio, J. L. Siddique, and J. , The Effect of Telephone-Administered Cognitive???Behavioral Therapy on Quality of Life among Patients with Multiple Sclerosis, Annals of Behavioral Medicine, vol.56, issue.5, pp.227-261, 2011.
DOI : 10.1037/0003-066X.56.3.218

N. Dalos, P. Rabins, B. Brooks, O. Donnell, and P. , Disease activity and emotional state in multiple sclerosis, Annals of Neurology, vol.8, issue.5, pp.573-580, 1983.
DOI : 10.1001/archneurpsyc.1922.02190130062009

O. Dahl, E. Stordal, S. Lydersen, and R. Midgard, Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Tr??ndelag County, Norway, Multiple Sclerosis Journal, vol.65, issue.12, pp.1495-501, 2009.
DOI : 10.1191/1352458503ms927oa

C. Desilva, M. Nurse, and K. Vokey, Steroid-Induced Psychosis Treated with Risperidone, The Canadian Journal of Psychiatry, vol.9, issue.4, pp.388-389, 2002.
DOI : 10.1089/cap.1999.9.315

W. Falk, M. Mahnke, and D. Poskanzer, Lithium Prophylaxis of Corticotropin-lnduced Psychosis, JAMA: The Journal of the American Medical Association, vol.241, issue.10, pp.1011-1013, 1979.
DOI : 10.1001/jama.1979.03290360027021

. Hanslik, Perception par les me decins internistes de la fre quence et de la ge ne induite par les effets inde sirables d'une corticothe rapie syste mique prolonge e, 2008.

L. Fardet, I. Petersen, and . Nazareth, Suicidal Behavior and Severe Neuropsychiatric Disorders Following Glucocorticoid Therapy in Primary Care, American Journal of Psychiatry, vol.169, issue.5, pp.491-497, 2012.
DOI : 10.1176/appi.ajp.2011.11071009

A. Feinstein, An examination of suicidal intent in patients with multiple sclerosis, Neurology, vol.59, issue.5, pp.674-682, 2002.
DOI : 10.1212/WNL.59.5.674

A. Feinstein, O. Connor, P. Gray, T. Feinstein, and K. , Pathological laughing and crying in multiple sclerosis: a preliminary report suggesting a role for the prefrontal cortex1999, pp.69-73

S. Finger, A Happy State of Mind, Archives of Neurology, vol.55, issue.2, pp.241-50, 1998.
DOI : 10.1001/archneur.55.2.241

T. Fleming and . Flood, Steroid-induced psychosis complicating orthognathic surgery: A case report, British Dental Journal, vol.42, issue.10, pp.647-648, 2005.
DOI : 10.1016/S0266-4356(03)00192-X

URL : http://www.nature.com/bdj/journal/v199/n10/pdf/4812929a.pdf

G. Franklin, L. Nelson, C. Filley, and R. Heaton, Cognitive Loss in Multiple Sclerosis, Archives of Neurology, vol.46, issue.2, pp.162-167, 1989.
DOI : 10.1001/archneur.1989.00520380066014

A. Gassab, M. Mechri, N. Bacha, L. Gaddour, and . Gaha, Affective temperaments in the bipolar and unipolar disorders: distinctive profiles and relationship with clinical features, pp.477-525, 2008.

A. Gaskill, F. Foley, J. Kolzet, and M. Picone, Disabil Rehabil. Suicidal thinking in multiple sclerosis, pp.17-181528, 2011.

A. Gift, R. Wood, and C. Cahill, Depression, somatization and steroid use in chronic obstructive pulmonary disease, International Journal of Nursing Studies, vol.26, issue.3, pp.281-287, 1989.
DOI : 10.1016/0020-7489(89)90009-6

G. Gilad and J. Rabey, Gilad VH Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stress, pp.2401-2409, 1987.

L. Goldman and J. Goveas, Olanzapine Treatment of Corticosteroid-Induced Mood Disorders, Psychosomatics, vol.43, issue.6, pp.495-497, 2002.
DOI : 10.1176/appi.psy.43.6.495

R. Hall, M. Popkin, S. Stickney, and E. Gardner, Presentation of the Steroid Psychoses, The Journal of Nervous and Mental Disease, vol.167, issue.4, pp.229-236, 1979.
DOI : 10.1097/00005053-197904000-00006

F. Hanne, R. Harbo, M. Gold, and . Tintoré, Sex and gender issues in multiple sclerosis, Ther Adv Neurol Disrder, vol.6, issue.4, pp.237-248, 2013.

R. Haskett, Diagnostic categorization of psychiatric disturbance in Cushing's syndrome, American Journal ofPsychiatry, vol.142, pp.911-916, 1985.

S. S. Hayreh and . Watson, Prednisolone-21-stearoylglycolate in scleritis., British Journal of Ophthalmology, vol.54, issue.6, pp.394-398, 1970.
DOI : 10.1136/bjo.54.6.394

URL : http://bjo.bmj.com/content/bjophthalmol/54/6/394.full.pdf

C. Jacobsen, Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study, Journal of Neurology, Neurosurgery & Psychiatry, vol.33, issue.10, pp.1109-1124, 2014.
DOI : 10.1002/hbm.21279

URL : http://jnnp.bmj.com/content/jnnp/85/10/1109.full.pdf

K. Jones, D. Ford, and P. Jones, A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register, PLoS ONE, vol.7, issue.7, pp.41910-41920, 2012.
DOI : 10.1371/journal.pone.0041910.s001

M. Korostil and A. Feinstein, Anxiety disorders and their clinical correlates in multiples sclrosis, 2007.

. Köhler-forsberg and . Buttenschøn, Brain Association between C-reactive protein (CRP) with depression symptom severity and speci fic depressive symptoms in major depression.Behav Immun, pp.889-159130062, 2017.

D. Kos and K. , Origin of Fatigue in Multiple Sclerosis: Review of the Literature, Neurorehabilitation and Neural Repair, vol.21, issue.11, 2008.
DOI : 10.1002/(SICI)1097-4598(199808)21:8<1068::AID-MUS12>3.0.CO;2-Q

. Kosmidis and G. Bozikas, Familial Comorbidity of Bipolar Disorder and Multiple Sclerosis: Genetic Susceptibility, Coexistence or Causal Relationship?, Behavioural Neurology, vol.25, issue.4, pp.341-350, 2012.
DOI : 10.1155/2012/894128

URL : http://doi.org/10.1155/2012/894128

T. Kramer and E. Cottingham, Risperidone in the Treatment of Steroid-Induced Psychosis, Journal of Child and Adolescent Psychopharmacology, vol.9, issue.4, pp.315-316, 1999.
DOI : 10.1089/cap.1999.9.315

J. F. Kurtzke, Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS), Neurology, vol.33, issue.11, pp.1444-1452, 1983.
DOI : 10.1212/WNL.33.11.1444

A. Krystal and C. Coffey, Neuropsychiatric considerations in the use of electroconvulsive therapy, J Neuropsychiatry Clin Neurosci, vol.9, pp.283-92, 1997.

L. C. Politte, J. C. Huffman, A. Theodore, and . Stern, Neuropsychiatric Manifestations of Multiple Sclerosis, The Primary Care Companion to The Journal of Clinical Psychiatry, vol.10, issue.04, pp.318-324, 2008.
DOI : 10.4088/PCC.v10n0408

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528238/pdf

M. Leboyer, Is it time for immuno-psychiatry in bipolar disorder and suicidal behaviour?, Acta Psychiatrica Scandinavica, vol.132, issue.3, pp.159-60, 2015.
DOI : 10.1111/acps.12433

L. Page, E. Veillard, D. Lebrun, and C. , Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial, The Lancet, vol.386, issue.9997
DOI : 10.1016/S0140-6736(15)61137-0

L. Scanff, Y. Stephana, A. Arlettazb, H. Portierb, and K. , Effets psychologiques d???une administration de courte dur??e de prednisolone, Science & Sports, vol.23, issue.2, pp.91-93, 2008.
DOI : 10.1016/j.scispo.2007.10.013

D. Lewis and R. Smith, Steroid-induced psychiatric syndromes, Journal of Affective Disorders, vol.5, issue.4, pp.319-332, 1983.
DOI : 10.1016/0165-0327(83)90022-8

L. L. Judd, M. D. Pamela, P. D. Schettler, and M. D. Sherwood-brown, Adverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects, Ph.D.Adverse Consequences of Glucocorticoid Medication:Psychological, Cognitive, and Behavioral Effects, pp.1045-1051, 2014.
DOI : 10.1176/appi.ajp.2014.13091264

A. Louveau, I. Smirnov, and . Keyes, Structural and functional features of central nervous system lymphatic vessels, Nature, vol.14, issue.7560, pp.337-378, 2015.
DOI : 10.1097/00019052-200106000-00006

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506234

L. Paul, P. Jens, @. @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@, . @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@, . @@@@@@@@@@@@@@@@@@@@ et al., Mortality in multiple sclerosis: metaanalysis of standardised mortality ratios, Neuropathology of stress, vol.12787, issue.13, pp.109-13324, 2014.

. @@@@@@@@@@@@@@@@@@@@@@, W. I. Mcdonald, A. Compston, G. Edan, D. Goodkin et al., Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis, 2001.

M. Michaelis, S. A. Roberts, M. H. Wilkinson, S. M. Diamond, I. D. Mclelland et al., The prevalence of cognitive impairment in a community survey of multiple sclerosis, British Journal of Clinical Psychology, vol.30, issue.4, pp.333-348, 1991.
DOI : 10.1111/j.2044-8260.1991.tb00954.x

C. Morin and L. Fardel, Sytemic glucocorticoid therapy: rik factors for reported adverse events and beliefs about the drugs. A cross sectional online survey of 820 patients, pp.2119-2145, 2015.

. Monassier, Les anti-in flammatoires steroidiens, 2005.

S. A. Morrow, C. A. Stoian, . Dmitrovic, S. C. Chan, and L. M. Metz, The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis, Neurology, vol.63, issue.6, pp.1079-1080, 2004.
DOI : 10.1212/01.WNL.0000138572.82125.F5

S. Morrow, J. Barr, and H. Rosehart, Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses, Journal of Affective Disorders, vol.187, pp.142-148, 2015.
DOI : 10.1016/j.jad.2015.08.040

D. Naber, P. Sand, and B. Heigl, Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment: a prospective study. Psychoneuro-endocrinology, pp.25-31, 1996.

J. Neumaier and T. J. Sexton, Corticosteroids regulate 5-HT1A but not 5-HT1B receptor mRNA in rat hippocampus, Molecular Brain Research, vol.82, issue.1-2, pp.65-73, 2000.
DOI : 10.1016/S0169-328X(00)00181-9

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847791/pdf

N. J. Volpe and M. , The Optic Neuritis Treatment Trial :A Definitive Answer and Profound Impact With Unexpected Results, Arch Ophthalmol, pp.996-1005, 2008.

K. Nishimura, M. Harigai, M. Omori, E. Sato, and M. Hara, Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus, Psychoneuroendocrinology, vol.33, issue.3, pp.395-403, 2008.
DOI : 10.1016/j.psyneuen.2007.12.007

C. Nicholl, N. Lincoln, V. Francis, and T. Stephan, Assessment of emotional problems in people with multiple sclerosis, Clinical Rehabilitation, vol.22, issue.6, pp.657-68, 2001.
DOI : 10.1023/A:1018731415172

E. Olsen, S. Carson, and E. Turney, Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata, Archives of Dermatology, vol.128, issue.11, pp.1467-1473, 1992.
DOI : 10.1001/archderm.1992.01680210045005

S. Patten, C. A. Beck, J. V. Williams, C. Barbui, and L. M. Metz, Major depression in multiple sclerosis: A population-based perspective, Neurology, vol.61, issue.11, pp.1524-1527, 2003.
DOI : 10.1212/01.WNL.0000095964.34294.B4

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.581.3646

S. Patten, Exogenous corticosteroids and major depression in the general population, Journal of Psychosomatic Research, vol.49, issue.6, pp.447-456, 2000.
DOI : 10.1016/S0022-3999(00)00187-2

P. Moore-a, C. Hirst-a, K. E. Harding-hannah-clarkson, T. P. Pickersgill, and N. P. Robertson, Multiple sclerosis relapses and depression, Journal of Psychosomatic Research, vol.73, issue.4, pp.272-276, 2012.
DOI : 10.1016/j.jpsychores.2012.08.004

F. Philippart, Corticotherapy in emergency department: an update, Re animation, vol.15, pp.533-539, 2006.

C. Polman, S. Reingold, B. Banwell, M. Clanet, J. Cohen et al., Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Annals of Neurology, vol.64, issue.suppl 2, pp.292-302, 2010.
DOI : 10.1002/ana.21464

URL : http://onlinelibrary.wiley.com/doi/10.1002/ana.22366/pdf

M. Pompili, A. Forte, M. Palermo, H. Stefani, D. Lamis et al., Suicide risk in multiple sclerosis: A systematic review of current literature, Journal of Psychosomatic Research, vol.73, issue.6, 2012.
DOI : 10.1016/j.jpsychores.2012.09.011

P. Laura, H. Jeff, and S. Theodore, Neuropsychiatric Manifestations of Multiple Sclerosis, Prim Care Companion J Clini psychiatry, vol.10, pp.318-324, 2008.

C. M. Poser, D. W. Paty, L. Scheinberg, W. I. Mcdonald, F. A. Davis et al., New diagnostic criteria for multiple sclerosis: Guidelines for research protocols, Annals of Neurology, vol.122, issue.3, pp.227-231, 1983.
DOI : 10.1212/WNL.29.9_Part_2.3

M. Reckart and S. Eisendrath, Exogenous corticosteroid effects on mood and cognition: case presentations, Int J Psychosom, vol.37, issue.1-4, pp.57-61, 1990.

. Ricouxa, . Guitteny-collasb, . Sauvagetb, . Delvota, . Pottierc et al., Oral glucocorticoid-induced psychiatric side-effects: Focus on clinical speci ficities, incidence, risk factors and treatment. La Revue de Médecine Interne, pp.293-302, 2013.

H. P. Rome and F. J. Braceland, THE PSYCHOLOGICAL RESPONSE TO ACTH, CORTISONE, HYDROCORTISONE, AND RELATED STEROID SUBSTANCES, American Journal of Psychiatry, vol.108, issue.9, 1952.
DOI : 10.1176/ajp.108.9.641

M. Robert and . Sapolsky, Glucocorticoi ds and hippocampal atrophy in neuropsychiatric disorders, Archives of General Psychiatry, vol.57, issue.10, pp.925-960, 2000.

R. Pivonello, C. Simeoli, M. C. , and D. Martino, Alessia Cozzolino Neuropsychiatric disorders in Cushing's syndrome, Front Neurosci, vol.9, p.129, 2015.

A. Ruet, M. Deloire, J. Charré-morin, D. Hamel, and B. Brochet, Cognitive impairment differs between primary progressive and relapsing-remitting MS, Neurology, vol.80, issue.16, pp.80-1501, 2013.
DOI : 10.1212/WNL.0b013e31828cf82f

S. Saklad, Management of corticosteroid-induced psychosis with lithium, Clin Pharm, vol.6, issue.3, p.186, 1987.

S. A. Morrowa, J. Barrb, H. Roseharta, and S. Ulchc, Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses, Journal of Affective Disorders, vol.187, pp.142-143, 2015.
DOI : 10.1016/j.jad.2015.08.040

S. Simioni, M. Schluep, J. Annoni, M. Gschwind, P. Vuilleumier et al., Modi fications neurocomportemetales secondaires à la sclérose en plaques, Rev Med Suisse, pp.951-954, 2009.

R. Sapolsky, L. Krey, and B. Mcewen, The Neuroendocrinology of Stress and Aging: The Glucocorticoid Cascade Hypothesis*, Endocrine Reviews, vol.7, issue.3, pp.284-301, 1986.
DOI : 10.1210/edrv-7-3-284

A. L. Sayao, V. Devonshire, and H. Tremlett, Longitudinal follow-up of "benign" multiple sclerosis at 20 years, Neurology, vol.68, issue.7, pp.496-500, 2007.
DOI : 10.1212/01.wnl.0000253185.03943.66

G. A. Schumacker, G. Beebe, R. F. Kibler, L. T. Kurland, and T. , PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS, Annals of the New York Academy of Sciences, vol.43, issue.6, pp.552-568, 1965.
DOI : 10.1001/archneurpsyc.1939.02270170051002

Z. Siddiqui, S. Ramaswamy, and F. Petty, Quetiapine Therapy for Corticosteroid-Induced Mania, The Canadian Journal of Psychiatry, vol.76, issue.1, pp.77-85, 2005.
DOI : 10.1016/S0165-0327(02)00075-7

R. Silva and L. Tolstunov, Steroid-induced psychosis, Journal of Oral and Maxillofacial Surgery, vol.53, issue.2, pp.183-186, 1995.
DOI : 10.1016/0278-2391(95)90398-4

S. Simpson, H. Tan, P. Otahal, and B. Taylor, Anxiety, depression and fatigue at 5-year review following CNS demyelination, Acta Neurologica Scandinavica, vol.49, issue.6, pp.403-413, 2016.
DOI : 10.1002/art.11405

S. Simioni, M. Schluep, J. Annon, M. Gschwind, and P. Vuilleumier, Modi fications neurocomportemetales secondaires à la sclérose en plaques, Rev Med Suisse, pp.951-954, 2009.

W. Setiawan, Role of Translocator Protein Density, a Marker of Neuroinflammation, in the Brain During Major Depressive Episodes, JAMA Psychiatry, vol.72, issue.3, pp.268-75
DOI : 10.1001/jamapsychiatry.2014.2427

R. Schiffer and N. Wineman, Antidepressant pharmacotherapy of depression associated with multiple sclerosis, Am J Psychiatry, vol.147, pp.1493-1500, 1990.

S. Kusljic, B. Schons, .. D. , *. , E. Manias et al., Corticosteroid-induced psychiatric disturbances: It is time for pharmacists to take notice, Research in Social and Administrative Pharmacy, vol.12, issue.2, pp.355-360, 2016.
DOI : 10.1016/j.sapharm.2015.05.012

S. Lima, F. Simioni, S. Bruggimann, and L. , Perceived Behavioral Changes in Early Multiple Sclerosis, Behavioural Neurology, vol.18, issue.2, pp.81-90, 2007.
DOI : 10.1155/2007/674075

URL : http://doi.org/10.1155/2007/674075

M. N. Starkman, D. E. Schteingart, and M. A. Schork, Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels, 1981.

E. Stenager and J. , Multiple sclerosis: correlation of psychiatric admissions to onset of initial symptoms, Acta Neurologica Scandinavica, vol.16, issue.5, 1988.
DOI : 10.1212/WNL.21.12.1179

S. Venkatarangam, S. Kutcher, and R. Notkin, Secondary Mania with Steroid Withdrawal, The Canadian Journal of Psychiatry, vol.61, issue.280, pp.631-632, 1988.
DOI : 10.1159/000123142

K. Wada, N. Yamada, Y. Yamauchi, and S. Kuroda, Carbamazepine treatment of corticosteroid-induced mood disorder, Journal of Affective Disorders, vol.65, issue.3, pp.315-322, 2001.
DOI : 10.1016/S0165-0327(00)00249-4

T. Warrington and M. Bostwick, Psychiatric Adverse Effects of Corticosteroids, Mayo Clinic Proceedings, vol.81, issue.10, pp.1361-1367, 2006.
DOI : 10.4065/81.10.1361

B. G. Weinshenker and M. Rodriguez, EPIDEMIOLOGY OF MULTIPLE SCLEROSIS, Neurologic Clinics, vol.14, issue.2, pp.533-564, 1995.
DOI : 10.1016/S0733-8619(05)70257-7

O. Wolkowitz, Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids???, Psychoneuroendocrinology, vol.19, issue.3, pp.233-255, 1994.
DOI : 10.1016/0306-4530(94)90064-7

. Wolkowitz, . @@@@@@@@@@@@@@@@@@@@@@@@, R. Young, J. Biggs, and D. Meyer, Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids???, Psychoneuroendocrinology, vol.19, issue.3, pp.233-255, 1978.
DOI : 10.1016/0306-4530(94)90064-7